We are live on
!
Find out more
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
HZNP
Delisted
HZNP was delisted on the 5th of October, 2023.
519 hedge funds and large institutions have $21.8B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2023 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 160 increasing their positions, 209 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
3% less capital invested
Capital invested by funds: $22.5B → $21.8B (-$721M)
6% less funds holding
Funds holding: 553 → 519 (-34)
13% less funds holding in top 10
Funds holding in top 10: 83 → 72 (-11)
23% less repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 209
35% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 82
40% less call options, than puts
Call options by funds: $2.21B | Put options by funds: $3.69B
Holders
519
Holders Change
-34
Holders Change %
-6.15%
% of All Funds
8.15%
Holding in Top 10
72
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-13.25%
% of All Funds
1.13%
New
53
Increased
160
Reduced
209
Closed
82
Calls
$2.21B
Puts
$3.69B
Net Calls
-$1.48B
Net Calls Change
-$865M
Top Buyers
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$699M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$158M |
| 3 |
D.E. Shaw & Co
New York
|
+$154M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$141M |
| 5 |
SCM
Segantii Capital Management
Hong Kong
|
+$114M |
